Intercept Pharmaceuticals: Q2 Earnings Insights

Intercept Pharmaceuticals ICPT reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Intercept Pharmaceuticals missed estimated earnings by 525.0%, reporting an EPS of $-0.25 versus an estimate of $-0.04.

Revenue was down $24.82 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.32 which was followed by a 1.63% drop in the share price the next day.

Here's a look at Intercept Pharmaceuticals's past performance:

To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.